SPMMF yields 224.72% · PFE yields 6.13%● Live data
📍 SPMMF pulled ahead of the other in Year 1
Combined, SPMMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPMMF + PFE for your $10,000?
Space-Communication Ltd. provides satellite communication services worldwide. The company offers on-the-move connectivity solutions; satellite broadband services, including high-speed two-way internet, broadband internet access, B2B and B2C, point-to-multipoint streaming, congestion-free IP trunking, and on-demand services; and satellite broadcasting services, such as DTH and TV/audio origination and distribution, redundancy and backup, encryption, satellite news gathering, video signals packaging and up-linking, TV channels retransmission, and satellite TV programs broadcasting services. It also provides hybrid cellular-satellite internet solutions; cross-region connectivity services; and satellite teleport services. In addition, the company offers corporate and government network solutions comprising local area network interconnection, VSAT network, satellite VPN, and data transmission services, as well as delivery of video, voice, and data to remote locations, including videoconference, telephony, fax transmissions, etc. Further, it provides point of sale applications, such as ATM and inventory reports; and internet applications. The company was founded in 1989 and is based in Ramat Gan, Israel. Space-Communication Ltd. is a subsidiary of Eurocom Holdings (1979) Ltd.
Full SPMMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.